Ellen Goldberg
Director/Board Member bij CASTLE BIOSCIENCES, INC.
Vermogen: 210 536 $ op 31-03-2024
Profiel
Ellen Goldberg is an Independent Director at Castle Biosciences, Inc. She previously worked as the Vice President-Marketing at Crescendo Bioscience LLC from 2009 to 2011.
Ms. Goldberg holds a graduate degree and an MBA from Stanford University.
She also has an undergraduate degree from Yale University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CASTLE BIOSCIENCES, INC.
0.03% | 14-07-2023 | 9 505 ( 0.03% ) | 210 536 $ | 31-03-2024 |
Actieve functies van Ellen Goldberg
Bedrijven | Functie | Begin |
---|---|---|
CASTLE BIOSCIENCES, INC. | Director/Board Member | 16-07-2021 |
Eerdere bekende functies van Ellen Goldberg
Bedrijven | Functie | Einde |
---|---|---|
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Sales & Marketing | 01-01-2011 |
Opleiding van Ellen Goldberg
Stanford University | Graduate Degree |
Yale University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CASTLE BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |